Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Endothelial Function
100%
Atorvastatin
100%
Short-term Effects
100%
First-degree Relatives
80%
Placebo
60%
Flow-mediated Dilation
60%
Interleukin-6
40%
Insulin Resistance
40%
Plasma Markers
40%
Homeostatic Model
40%
Inflammation Markers
40%
Highly Sensitive C-reactive Protein
40%
Normal Glucose Tolerance
20%
Statin Therapy
20%
Endothelial Dysfunction
20%
Double-blind Placebo-controlled Trial
20%
Inflammatory Markers
20%
Insulin Resistance Index
20%
Type 2 Diabetes Mellitus Patients
20%
Impaired Flow
20%
Soluble Adhesion Molecules
20%
Plasma Lipids
20%
Type 2 Diabetes Mellitus Risk
20%
High-risk Subjects
20%
Maternal Diabetes Mellitus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atorvastatin
100%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
80%
Insulin Resistance
60%
Interleukin 6
40%
C Reactive Protein
40%
Inflammation
40%
Statin (Protein)
20%
Diabetes Mellitus
20%
Endothelial Dysfunction
20%
Normal Human
20%
Cell Adhesion Proteins
20%